CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition - Test2 - elhamkhani - TriplyDB

CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition

CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition

http://www.wikidata.org/entity/Q35020718

about

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms.Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines.Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples.Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.Control of HIV-1 infection by soluble factors of the immune response.TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.Gene therapy progress and prospects: novel gene therapy approaches for AIDS.Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics--a mini review.Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin Antimicrobial peptides and surfactant proteins in ruminant respiratory tract disease Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239 Natural antimicrobial peptides as promising anti-HIV candidates.Collectins and cationic antimicrobial peptides of the respiratory epithelia.Influence of prothymosin-alpha on HIV-1 target cells.Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.The role of cathelicidin and defensins in pulmonary inflammatory diseases.Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells.Host defense peptides in the oral cavity and the lung: similarities and differences.Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs.Defensins in viral infections.Innate antiviral immunity of periodontal tissue.α-Defensins in human innate immunity.Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.Differential effects on human immunodeficiency virus type 1 replication by alpha-defensins with comparable bactericidal activities.Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity.Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection.Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva.MxA expression induced by α-defensin in healthy human periodontal tissue.

P2860

Q21261765-34C31635-A182-4F53-8591-2CECAD4A4137 Q27670782-B0C686A3-E217-40FA-9BF3-1BEA41978413 Q28257799-FA7DBF96-1289-47DC-9D80-BF940A974FB6 Q30432007-978FBA8A-8AC9-45A0-A907-EEDC2E127DB9 Q33535953-0F294FA4-5F7B-4DA5-907A-07C8A0899393 Q33543787-F14E5825-DAA6-4F57-8CCC-B190FAEABEA6 Q33669536-18BF6A62-A9FC-43CC-9E13-A3A921977BBD Q33842057-506E9CEE-A1AB-47ED-A438-B9F2F613A1A5 Q34124118-0FDEBBA6-261C-4EBB-AD51-3FF1BF4AE417 Q34379985-4C1EAD57-575A-486C-BC19-2018CEE99F20 Q34589778-0305A810-85CE-401D-8EEE-261938AFE16E Q34976381-6F979149-963B-420B-A1F9-507A90FD7C62 Q35030053-9D8E8F96-4F33-491E-ABD3-17A4A1EC3DE8 Q35752416-90920051-B784-4F83-9ED6-1C2CD05344E7 Q35818922-A6F3A249-9893-4E4F-B48E-4FF432730F29 Q36036704-60338929-7C5D-4358-9CC4-7AFFFCBF8061 Q36054193-C08B9596-45AA-4638-B415-7608381E36C6 Q36203490-CA6F4DFB-2E6F-4EE7-93D1-EAEE650F0AE3 Q36217242-5317900A-A854-41AE-B42C-29355C801CCC Q36248322-ED9AF9CB-F0AB-465A-8BE9-A85CEC619F71 Q36506883-B29E273D-71E3-4636-93AE-6E3D763CAE1E Q36514316-553E0A2F-90C1-4F5E-8A2F-33933A5903B7 Q36590997-0822ABFF-A0A8-4F51-960E-BB30102DA7F0 Q36864562-0F041430-3D8D-42A5-ADDF-AC2EB0341B3E Q36879697-8A26CCDA-E2AF-42E6-A4CC-57E0D65F7C8D Q36922272-9CF0B5E7-6369-4B71-AEDE-463144246B3A Q37157103-48EC03F6-C4ED-484E-8240-85F6F6A77E38 Q37276479-6F3C5619-71B4-440B-8865-035A116A8FC9 Q37375957-8EF493B3-970F-4E82-947E-F8A88865CDEB Q37576464-C4022C19-27CB-4D32-9AFF-AF41FE9DF651 Q37726739-25973BB8-1A07-4315-8882-5B32839123F9 Q37866356-B4C8F023-4BF6-448F-B3CB-6A7CECC1D556 Q37968296-527769EF-7096-44FF-9DC9-152B4F96BF7D Q38098176-FDF0D1D1-9517-4DD6-9468-17B1F77637D2 Q40214947-372C79FF-FE9A-4DB6-BFE1-C6341A42B8C0 Q40577040-35144B4C-8705-4897-BFD7-F154685CB257 Q42793707-0FE28156-24FA-459C-B60A-E585B23152FD Q43119125-9F95BFCC-ED9D-4485-91F2-D0C94114D16F Q44865930-90537DA8-AA7E-41C4-AB37-425C5E9C9A5F Q45722167-7F8A7051-FDF8-4A66-BA25-4DEE10DAE3C1

P2860

CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition

http://www.wikidata.org/entity/Q35020718

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@ast

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@en

type

label

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@ast

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@en

prefLabel

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@ast

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@en

P1433

Q35020718-3057DAD2-E06C-40B1-801D-4A9E97847BBE

P1476

Q35020718-3A00690D-40D4-4D01-A75C-940F2AB77FFD

P2093

Q35020718-0A5E4A2F-3397-47C3-B07E-3DBF25156C4E

Q35020718-3B9E57E7-1619-4B43-86AA-75F21076D34B

Q35020718-BECB1CCD-1713-4CBD-BBB6-AD27882DF639

Q35020718-E244D6EB-9E03-4340-9282-0A23EB29FC66

P2860

Q35020718-0473C376-2A58-43F7-A1A1-AF9BB3B0177F

Q35020718-0BA3571A-72F9-4E14-9396-58269BDA8100

Q35020718-0D036B12-CD53-438E-B19C-5E5FE6A11D3E

Q35020718-1769D2EB-D86F-4188-81A6-F51C8B4CABF3

Q35020718-1A31C33C-F25C-472C-9E10-DD1F1C8AC006

Q35020718-209DF69C-CFB8-4F70-88F9-A0498B0E854A

Q35020718-348BE328-A29A-4ADB-85A6-329ADA37393F

Q35020718-3B4BEB8F-FB37-4667-B2E2-A9CFB6388D4E

Q35020718-3CA534B3-BAC6-4E91-8F86-159F5904553C

Q35020718-44C4AADC-2CF5-4F5E-8FEC-EFB291E9D600

P304

Q35020718-016E883A-EC0A-4887-8FBF-A28434980DF1

P31

Q35020718-E778FAA2-DCAF-4573-B429-D5407F3DDD71

P356

Q35020718-B7267A62-D1CD-4005-9423-986A8CD58103

P407

Q35020718-4DDEBFC6-6DCD-41F0-85C4-B1A629D9D1B0

P433

Q35020718-97E8AFAB-FDEA-4DA9-A803-42D360AF5677

P478

Q35020718-D7519A97-1C8D-4735-B80F-6062376D9CC0

P577

Q35020718-3BF86038-B624-4205-BC27-542C9A124450

P698

Q35020718-555B5CCD-98AA-4A8B-AD76-CF94A291C3DC

P932

Q35020718-1A636ECB-475B-4599-B266-0486BA0BEB17

P356

JVI.77.12.6777-6784.2003

P1433

Journal of Virology

P1476

CAF-mediated human immunodefic ...... lpha-defensin-1 HIV inhibition

@en

P2093

Arevik Mosoian

http://www.w3.org/2001/XMLSchema#string

Fleur François

http://www.w3.org/2001/XMLSchema#string

Mary E Klotman

http://www.w3.org/2001/XMLSchema#string

Theresa Li-Yun Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

Defensins: antimicrobial and cytotoxic peptides of mammalian cells

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx

Human immunodeficiency virus induces phosphorylation of its cell surface receptor

Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.

P304

6777-6784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.12.6777-6784.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12767998

http://www.w3.org/2001/XMLSchema#string

P932

156196

http://www.w3.org/2001/XMLSchema#string